伊拉克Thi-Qar产碳青霉烯酶大肠杆菌临床分离株的表型和基因型特征

IF 1.3 Q4 MICROBIOLOGY
Moslim Mohsin Khalaf, Firas Srhan Abd Al-Mayahi
{"title":"伊拉克Thi-Qar产碳青霉烯酶大肠杆菌临床分离株的表型和基因型特征","authors":"Moslim Mohsin Khalaf, Firas Srhan Abd Al-Mayahi","doi":"10.18502/ijm.v17i2.18387","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>The emergence of carbapenem resistance in <i>Escherichia coli (E. coli)</i> poses an urgent threat. The study aims to assess carbapenem resistance and the presence of carbapenemase genes in <i>E. coli</i> clinical isolates from Thi-Qar Hospital, Iraq.</p><p><strong>Materials and methods: </strong>A total of 2203 specimens were collected from patients at two hospitals between January and October 2024. <i>E. coli</i> was identified via biochemical tests and confirmed with the Vitek2® system. Antibiotic sensitivity was evaluated using disc diffusion, and carbapenemase production was investigated through combined disc tests (CDT) and modified Hodge tests (MHT). PCR was used to detect carbapenemase genes.</p><p><strong>Results: </strong>Out of 2203 specimens, 1212 (55.02%) exhibited bacterial growth, with <i>E. coli</i> accounting for 15.35% (186/1212) of isolates. Among these, 40 (21.51%) were resistant to at least one carbapenem. CDT identified 10, and MHT identified 1 as a carbapenemase producer. The most detected gene was <i>bla</i> <sub>NDM</sub> (60.00%), followed by <i>bla</i> <sub>OXA</sub> (40.00%) and <i>bla</i> <sub>OXA-48</sub> (15.00%). <i>bla</i> <sub>OXA-51</sub> and <i>bla</i> <sub>VIM</sub> were found in 5.00% of isolates each. No <i>bla</i> <sub>KPC</sub>, <i>bla</i> <sub>NMC</sub>, <i>bla</i> <sub>IMI</sub>, <i>bla</i> <sub>GES</sub>, <i>bla</i> <sub>SPM</sub>, <i>bla</i> <sub>GIM</sub>, or <i>bla</i> <sub>SIM</sub> was detected.</p><p><strong>Conclusion: </strong>The high prevalence of carbapenem resistance and the corresponding encoding genes in <i>E. coli</i> in Thi-Qar province pose a concerning challenge for managing serious infections caused by this pathogen.</p>","PeriodicalId":14633,"journal":{"name":"Iranian Journal of Microbiology","volume":"17 2","pages":"268-277"},"PeriodicalIF":1.3000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Phenotypic and genotypic characterization of carbapenemase-producing <i>Escherichia coli</i> clinical isolates in Thi-Qar, Iraq.\",\"authors\":\"Moslim Mohsin Khalaf, Firas Srhan Abd Al-Mayahi\",\"doi\":\"10.18502/ijm.v17i2.18387\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objectives: </strong>The emergence of carbapenem resistance in <i>Escherichia coli (E. coli)</i> poses an urgent threat. The study aims to assess carbapenem resistance and the presence of carbapenemase genes in <i>E. coli</i> clinical isolates from Thi-Qar Hospital, Iraq.</p><p><strong>Materials and methods: </strong>A total of 2203 specimens were collected from patients at two hospitals between January and October 2024. <i>E. coli</i> was identified via biochemical tests and confirmed with the Vitek2® system. Antibiotic sensitivity was evaluated using disc diffusion, and carbapenemase production was investigated through combined disc tests (CDT) and modified Hodge tests (MHT). PCR was used to detect carbapenemase genes.</p><p><strong>Results: </strong>Out of 2203 specimens, 1212 (55.02%) exhibited bacterial growth, with <i>E. coli</i> accounting for 15.35% (186/1212) of isolates. Among these, 40 (21.51%) were resistant to at least one carbapenem. CDT identified 10, and MHT identified 1 as a carbapenemase producer. The most detected gene was <i>bla</i> <sub>NDM</sub> (60.00%), followed by <i>bla</i> <sub>OXA</sub> (40.00%) and <i>bla</i> <sub>OXA-48</sub> (15.00%). <i>bla</i> <sub>OXA-51</sub> and <i>bla</i> <sub>VIM</sub> were found in 5.00% of isolates each. No <i>bla</i> <sub>KPC</sub>, <i>bla</i> <sub>NMC</sub>, <i>bla</i> <sub>IMI</sub>, <i>bla</i> <sub>GES</sub>, <i>bla</i> <sub>SPM</sub>, <i>bla</i> <sub>GIM</sub>, or <i>bla</i> <sub>SIM</sub> was detected.</p><p><strong>Conclusion: </strong>The high prevalence of carbapenem resistance and the corresponding encoding genes in <i>E. coli</i> in Thi-Qar province pose a concerning challenge for managing serious infections caused by this pathogen.</p>\",\"PeriodicalId\":14633,\"journal\":{\"name\":\"Iranian Journal of Microbiology\",\"volume\":\"17 2\",\"pages\":\"268-277\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Iranian Journal of Microbiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18502/ijm.v17i2.18387\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/ijm.v17i2.18387","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景与目的:大肠杆菌中碳青霉烯类耐药的出现构成了一个紧迫的威胁。该研究旨在评估伊拉克Thi-Qar医院临床分离的大肠杆菌对碳青霉烯类药物的耐药性和碳青霉烯类酶基因的存在。材料与方法:于2024年1 - 10月在两所医院采集患者标本2203份。通过生化试验鉴定大肠杆菌,并用Vitek2®系统进行鉴定。采用圆盘扩散法评估抗生素敏感性,并通过联合圆盘试验(CDT)和改良霍奇试验(MHT)研究碳青霉烯酶的产生。PCR检测碳青霉烯酶基因。结果:2203份标本中,1212份(55.02%)有细菌生长,其中大肠杆菌占15.35%(186/1212)。其中40株(21.51%)对至少一种碳青霉烯类耐药。CDT鉴定出10,MHT鉴定出1是碳青霉烯酶产生物。检出最多的基因是bla NDM(60.00%),其次是bla OXA(40.00%)和bla OXA-48(15.00%)。bla OXA-51和bla VIM各占5.00%。未检测到bla KPC、bla NMC、bla IMI、bla GES、bla SPM、bla GIM、bla SIM。结论:齐卡尔省大肠杆菌碳青霉烯类耐药及其相关编码基因的高发,对防治该病原菌引起的严重感染提出了严峻的挑战。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Phenotypic and genotypic characterization of carbapenemase-producing Escherichia coli clinical isolates in Thi-Qar, Iraq.

Background and objectives: The emergence of carbapenem resistance in Escherichia coli (E. coli) poses an urgent threat. The study aims to assess carbapenem resistance and the presence of carbapenemase genes in E. coli clinical isolates from Thi-Qar Hospital, Iraq.

Materials and methods: A total of 2203 specimens were collected from patients at two hospitals between January and October 2024. E. coli was identified via biochemical tests and confirmed with the Vitek2® system. Antibiotic sensitivity was evaluated using disc diffusion, and carbapenemase production was investigated through combined disc tests (CDT) and modified Hodge tests (MHT). PCR was used to detect carbapenemase genes.

Results: Out of 2203 specimens, 1212 (55.02%) exhibited bacterial growth, with E. coli accounting for 15.35% (186/1212) of isolates. Among these, 40 (21.51%) were resistant to at least one carbapenem. CDT identified 10, and MHT identified 1 as a carbapenemase producer. The most detected gene was bla NDM (60.00%), followed by bla OXA (40.00%) and bla OXA-48 (15.00%). bla OXA-51 and bla VIM were found in 5.00% of isolates each. No bla KPC, bla NMC, bla IMI, bla GES, bla SPM, bla GIM, or bla SIM was detected.

Conclusion: The high prevalence of carbapenem resistance and the corresponding encoding genes in E. coli in Thi-Qar province pose a concerning challenge for managing serious infections caused by this pathogen.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.40
自引率
7.10%
发文量
96
审稿时长
12 weeks
期刊介绍: The Iranian Journal of Microbiology (IJM) is an international, multi-disciplinary, peer-reviewed journal that provides rapid publication of the most advanced scientific research in the areas of basic and applied research on bacteria and other micro-organisms, including bacteria, viruses, yeasts, fungi, microalgae, and protozoa concerning the development of tools for diagnosis and disease control, epidemiology, antimicrobial agents, clinical microbiology, immunology, Genetics, Genomics and Molecular Biology. Contributions may be in the form of original research papers, review articles, short communications, case reports, technical reports, and letters to the Editor. Research findings must be novel and the original data must be available for review by the Editors, if necessary. Studies that are preliminary, of weak originality or merely descriptive as well as negative results are not appropriate for the journal. Papers considered for publication must be unpublished work (except in an abstract form) that is not under consideration for publication anywhere else, and all co-authors should have agreed to the submission. Manuscripts should be written in English.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信